This case tells of history development of Daiichi Pharmaceutical (China) CompanyLtd. since started its marketing in China in 1988. the history is divided into three phases,each phase includes different medicine market environments and definite marketingstrategies.
本案例是讲述第一制药（中国）有限公司自1988年进入中国医药市场的发展过程，其过程分为三阶段，每一阶段都有其独特的医药市场环境和营销内容。
参考来源 - 《案例》：第一制药（中国）有限公司——“必妥”产品在中国市场的开发·2,447,543篇论文数据，部分数据来源于NoteExpress
从制药商第一次开始出售处方药时，他们就给开药的医生拍马屁了。
Ever since drugmakers first started selling prescription medicines, they've been currying favor with doctors who write the orders.
然而，在通常情况下，第一个仿制药并不能在市场上自由的销售，因为专利所有人都会采取销售品牌药物的“授权”仿制药的措施进行干扰。
Often, however, the first generic does not have a free run, because patent-owners have taken to selling "authorised" generic versions of branded pills.
制药大亨r . J . Kirk的第一次创业就栽了个大跟头，他对这段经历既懊悔又感激。
Pharmaceutical tycoon R.J. Kirk's first venture was a flop — an experience he regrets but appreciates.
应用推荐